TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs117415762
log Bayes Factor = 13.5576
Chromosome 9   position 77,698,356  (GRCh37) Explore rs117415762 on Ensembl!
Variant rs117415762 is part of Cluster X0089

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
1.000 0.000 0.000
Chapter II Neoplasms
1.000 0.000 0.000
# Top node
1.000 0.000 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
1.000 0.000 0.000
C79 Secondary malignant neoplasm of other sites
0.999 0.001 0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes
0.998 0.002 0.000
Chapter XV Pregnancy, childbirth and the puerperium
0.998 0.002 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.994 0.006 0.000
Chapter XX External causes of morbidity and mortality
0.993 0.007 0.000
Chapter V Mental and behavioural disorders
0.992 0.008 0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.992 0.008 0.000
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems
0.986 0.014 0.000
C78.0 Secondary malignant neoplasm of lung
0.986 0.014 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.983 0.017 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.982 0.018 0.000
Z51.5 Palliative care
0.974 0.026 0.000
Z51 Other medical care
0.974 0.026 0.000
Y43 Primarily systemic agents
0.971 0.029 0.000
C78.7 Secondary malignant neoplasm of liver
0.968 0.032 0.000
C77.2 Intra-abdominal lymph nodes
0.967 0.033 0.000
Y43.3 Other antineoplastic drugs
0.963 0.037 0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.962 0.038 0.000
F30-F39 Mood [affective] disorders
0.962 0.038 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.961 0.039 0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.954 0.046 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.953 0.047 0.000
W00-W19 Falls
0.951 0.049 0.000
Chapter VI Diseases of the nervous system
0.946 0.054 0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.942 0.058 0.000
Z40-Z54 Persons encountering health services for specific procedures and health care
0.941 0.059 0.000
Chapter XXI Factors influencing health status and contact with health services
0.941 0.059 0.000
C50-C50 Malignant neoplasm of breast
0.940 0.060 0.000
C80 Malignant neoplasm without specification of site
0.925 0.075 0.000
D00-D09 In situ neoplasms
0.920 0.080 0.000
C51-C58 Malignant neoplasms of female genital organs
0.913 0.087 0.000
F00-F09 Organic, including symptomatic, mental disorders
0.910 0.090 0.000
O36 Maternal care for other known or suspected foetal problems
0.909 0.091 0.000
Z51.1 Chemotherapy session for neoplasm
0.905 0.095 0.000
W19 Unspecified fall
0.901 0.099 0.000
Z51.8 Other specified medical care
0.898 0.102 0.000
C50 Malignant neoplasm of breast
0.897 0.103 0.000
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue
0.894 0.106 0.000
Z45 Adjustment and management of implanted device
0.892 0.108 0.000
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
0.891 0.109 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.890 0.110 0.000
O20-O29 Other maternal disorders predominantly related to pregnancy
0.887 0.113 0.000
R22 Localised swelling, mass and lump of skin and subcutaneous tissue
0.879 0.121 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.879 0.121 0.000
O32 Maternal care for known or suspected malpresentation of foetus
0.877 0.123 0.000
G90-G99 Other disorders of the nervous system
0.876 0.124 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.870 0.130 0.000
O30 Multiple gestation
0.869 0.131 0.000
R21 Rash and other nonspecific skin eruption
0.863 0.137 0.000
F32 Depressive episode
0.861 0.139 0.000
D04 Carcinoma in situ of skin
0.860 0.140 0.000
S50-S59 Injuries to the elbow and forearm
0.859 0.141 0.000
R40-R46 Symptoms and signs involving cognition, perception, emotional state and behaviour
0.854 0.146 0.000
Z51.0 Radiotherapy session
0.853 0.147 0.000
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium
0.851 0.149 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.849 0.151 0.000
S00-S09 Injuries to the head
0.847 0.153 0.000
T39.1 4-Aminophenol derivatives
0.846 0.154 0.000
Z45.2 Adjustment and management of vascular access device
0.843 0.157 0.000
R22.3 Localised swelling, mass and lump, upper limb
0.841 0.159 0.000
F31 Bipolar affective disorder
0.841 0.159 0.000
C81 Hodgkin's disease
0.840 0.160 0.000
F60-F69 Disorders of adult personality and behaviour
0.839 0.161 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.839 0.161 0.000
T39.0 Salicylates
0.835 0.165 0.000
C56 Malignant neoplasm of ovary
0.834 0.166 0.000
C80.0 Malignant neoplasm, primary site unknown, so stated
0.832 0.168 0.000
W19.9 Unspecified place
0.831 0.169 0.000
O36.8 Maternal care for other specified foetal problems
0.828 0.172 0.000
F33 Recurrent depressive disorder
0.827 0.173 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.826 0.174 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.826 0.174 0.000
C77.8 Lymph nodes of multiple regions
0.822 0.178 0.000
C50.3 Lower-inner quadrant of breast
0.821 0.179 0.000
G80-G83 Cerebral palsy and other paralytic syndromes
0.817 0.183 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.816 0.184 0.000
Z45.1 Adjustment and management of infusion pump
0.811 0.189 0.000
Z51.2 Other chemotherapy
0.810 0.190 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.808 0.192 0.000
R42 Dizziness and giddiness
0.803 0.197 0.000
C15-C26 Malignant neoplasms of digestive organs
0.802 0.198 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.801 0.199 0.000
D03 Melanoma in situ
0.800 0.200 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.799 0.201 0.000
C91 Lymphoid leukaemia
0.796 0.204 0.000
Y52 Agents primarily affecting the cardiovascular system
0.793 0.207 0.000
C77.0 Lymph nodes of head, face and neck
0.791 0.209 0.000
F05 Delirium, not induced by alcohol and other psychoactive substances
0.790 0.210 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.790 0.210 0.000
W50-W64 Exposure to animate mechanical forces
0.789 0.211 0.000
C77.9 Lymph node, unspecified
0.786 0.214 0.000
O30.0 Twin pregnancy
0.785 0.214 0.000
C78.2 Secondary malignant neoplasm of pleura
0.784 0.216 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.784 0.216 0.000
S90-S99 Injuries to the ankle and foot
0.783 0.217 0.000
O36.0 Maternal care for rhesus isoimmunisation
0.781 0.219 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.777 0.222 0.000
F03 Unspecified dementia
0.777 0.223 0.000
S70-S79 Injuries to the hip and thigh
0.776 0.224 0.000
S51 Open wound of forearm
0.775 0.225 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.775 0.225 0.000
S20-S29 Injuries to the thorax
0.775 0.225 0.000
S10-S19 Injuries to the neck
0.774 0.226 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.774 0.226 0.000
C80.9 Malignant neoplasm, unspecified
0.773 0.227 0.000
O26 Maternal care for other conditions predominantly related to pregnancy
0.773 0.227 0.000
O47 False labour
0.773 0.227 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.771 0.229 0.000
C77.5 Intrapelvic lymph nodes
0.768 0.232 0.000
C85.1 B-cell lymphoma, unspecified
0.767 0.233 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.766 0.233 0.000
G40-G47 Episodic and paroxysmal disorders
0.766 0.234 0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source
0.766 0.234 0.000
W19.2 School, other institution and public administrative area
0.766 0.234 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.764 0.236 0.000
V10-V19 Pedal cyclist injured in transport accident
0.763 0.237 0.000
O00-O08 Pregnancy with abortive outcome
0.763 0.237 0.000
O34 Maternal care for known or suspected abnormality of pelvic organs
0.762 0.238 0.000
O41 Other disorders of amniotic fluid and membranes
0.762 0.238 0.000
O32.5 Maternal care for multiple gestation with malpresentation of one foetus or more
0.758 0.241 0.000
T42.4 Benzodiazepines
0.758 0.242 0.000
O94-O99 Other obstetric conditions, not elsewhere classified
0.758 0.242 0.000
C50.5 Lower-outer quadrant of breast
0.757 0.243 0.000
C79.2 Secondary malignant neoplasm of skin
0.757 0.243 0.000
T15-T19 Effects of foreign body entering through natural orifice
0.755 0.245 0.000
F80-F89 Disorders of psychological development
0.753 0.247 0.000
O40 Polyhydramnios
0.753 0.247 0.000
W06 Fall involving bed
0.753 0.247 0.000
F40-F48 Neurotic, stress-related and somatoform disorders
0.752 0.248 0.000
T66-T78 Other and unspecified effects of external causes
0.749 0.251 0.000
Z48 Other surgical follow-up care
0.748 0.251 0.000
O85-O92 Complications predominantly related to the puerperium
0.748 0.252 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.748 0.252 0.000
X60-X84 Intentional self-harm
0.747 0.253 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.742 0.258 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.739 0.261 0.000
D04.3 Skin of other and unspecified parts of face
0.739 0.261 0.000
F32.3 Severe depressive episode with psychotic symptoms
0.739 0.261 0.000
C77.3 Axillary and upper limb lymph nodes
0.738 0.262 0.000
R23 Other skin changes
0.737 0.263 0.000
S02 Fracture of skull and facial bones
0.736 0.264 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.736 0.264 0.000
G93 Other disorders of brain
0.735 0.265 0.000
F60 Specific personality disorders
0.729 0.271 0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system
0.729 0.271 0.000
O16 Unspecified maternal hypertension
0.727 0.273 0.000
F33.9 Recurrent depressive disorder, unspecified
0.726 0.274 0.000
C77.1 Intrathoracic lymph nodes
0.725 0.275 0.000
G20-G26 Extrapyramidal and movement disorders
0.723 0.277 0.000
W18 Other fall on same level
0.723 0.277 0.000
T80-T88 Complications of surgical and medical care, not elsewhere classified
0.722 0.278 0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.721 0.279 0.000
Chapter XXII Codes for special purposes
0.718 0.282 0.000
O80-O84 Delivery
0.718 0.282 0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
0.717 0.283 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.717 0.283 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.717 0.283 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.717 0.283 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.717 0.283 0.000
Chapter XVI Certain conditions originating in the perinatal period
0.717 0.283 0.000
C78.4 Secondary malignant neoplasm of small intestine
0.717 0.283 0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.717 0.283 0.000
C78.1 Secondary malignant neoplasm of mediastinum
0.717 0.283 0.000
G99 Other disorders of nervous system in diseases classified elsewhere
0.717 0.283 0.000
C79.6 Secondary malignant neoplasm of ovary
0.716 0.284 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.716 0.284 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.716 0.284 0.000
G91 Hydrocephalus
0.716 0.284 0.000
T79-T79 Certain early complications of trauma
0.716 0.284 0.000
T33-T35 Frostbite
0.716 0.284 0.000
T26-T28 Burns and corrosions confined to eye and internal organs
0.716 0.284 0.000
T20-T25 Burns and corrosions of external body surface, specified by site
0.716 0.284 0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region
0.716 0.284 0.000
T00-T07 Injuries involving multiple body regions
0.716 0.284 0.000
F99-F99 Unspecified mental disorder
0.715 0.284 0.000
R22.9 Localised swelling, mass and lump, unspecified
0.714 0.285 0.000
Y44 Agents primarily affecting blood constituents
0.714 0.286 0.000
F32.2 Severe depressive episode without psychotic symptoms
0.713 0.287 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.713 0.287 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.713 0.287 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.713 0.287 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.713 0.287 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.713 0.287 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.713 0.287 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.713 0.287 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.713 0.287 0.000
T36 Poisoning by systemic antibiotics
0.713 0.287 0.000
C50.8 Overlapping lesion of breast
0.713 0.287 0.000
G30-G32 Other degenerative diseases of the nervous system
0.713 0.287 0.000
O32.8 Maternal care for other malpresentation of foetus
0.712 0.288 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.712 0.288 0.000
Y35-Y36 Legal intervention and operations of war
0.712 0.288 0.000
Y10-Y34 Event of undetermined intent
0.712 0.288 0.000
Y00-Y09 Assault
0.712 0.288 0.000
X85-X99 Assault
0.712 0.288 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.712 0.288 0.000
X50-X57 Overexertion, travel and privation
0.712 0.288 0.000
X30-X39 Exposure to forces of nature
0.712 0.288 0.000
X20-X29 Contact with venomous animals and plants
0.712 0.288 0.000
X10-X19 Contact with heat and hot substances
0.712 0.288 0.000
X00-X09 Exposure to smoke, fire and flames
0.712 0.288 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.712 0.288 0.000
W75-W84 Other accidental threats to breathing
0.712 0.288 0.000
W65-W74 Accidental drowning and submersion
0.712 0.288 0.000
V98-V99 Other and unspecified transport accidents
0.712 0.288 0.000
V95-V97 Air and space transport accidents
0.712 0.288 0.000
V90-V94 Water transport accidents
0.712 0.288 0.000
V80-V89 Other land transport accidents
0.712 0.288 0.000
V70-V79 Bus occupant injured in transport accident
0.712 0.288 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.712 0.288 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.712 0.288 0.000
V40-V49 Car occupant injured in transport accident
0.712 0.288 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.712 0.288 0.000
V01-V09 Pedestrian injured in transport accident
0.712 0.288 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.712 0.288 0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.711 0.288 0.000
F70-F79 Mental retardation
0.711 0.288 0.000
C77.4 Inguinal and lower limb lymph nodes
0.711 0.289 0.000
R45 Symptoms and signs involving emotional state
0.711 0.289 0.000
R22.1 Localised swelling, mass and lump, neck
0.709 0.291 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.708 0.291 0.000
O45 Premature separation of placenta [abruptio placentae]
0.707 0.293 0.000
O44 Placenta praevia
0.707 0.293 0.000
O43 Placental disorders
0.707 0.293 0.000
O35 Maternal care for known or suspected foetal abnormality and damage
0.707 0.293 0.000
O33 Maternal care for known or suspected disproportion
0.707 0.293 0.000
O31 Complications specific to multiple gestation
0.707 0.293 0.000
C55 Malignant neoplasm of uterus, part unspecified
0.706 0.294 0.000
D04.6 Skin of upper limb, including shoulder
0.706 0.294 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.706 0.294 0.000
Chapter I Certain infectious and parasitic diseases
0.706 0.294 0.000
D04.5 Skin of trunk
0.705 0.295 0.000
R44 Other symptoms and signs involving general sensations and perceptions
0.705 0.295 0.000
F05.9 Delirium, unspecified
0.705 0.295 0.000
Y59 Other and unspecified vaccines and biological substances
0.704 0.295 0.000
Y58 Bacterial vaccines
0.704 0.295 0.000
Y57 Other and unspecified drugs and medicaments
0.704 0.295 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.704 0.295 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.704 0.295 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.704 0.295 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.704 0.295 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.704 0.295 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.704 0.295 0.000
Y48 Anaesthetics and therapeutic gases
0.704 0.295 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.704 0.295 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.704 0.295 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.704 0.295 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.704 0.296 0.000
C95 Leukaemia of unspecified cell type
0.704 0.296 0.000
C94 Other leukaemias of specified cell type
0.704 0.296 0.000
C93 Monocytic leukaemia
0.704 0.296 0.000
C88 Malignant immunoproliferative diseases
0.704 0.296 0.000
C86 Other specified types of T/NK-cell lymphoma
0.704 0.296 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.704 0.296 0.000
O28 Abnormal findings on antenatal screening of mother
0.704 0.296 0.000
C50.9 Breast, unspecified
0.702 0.298 0.000
C81.1 Nodular sclerosis
0.701 0.299 0.000
G43 Migraine
0.701 0.299 0.000
F31.9 Bipolar affective disorder, unspecified
0.701 0.299 0.000
R20 Disturbances of skin sensation
0.699 0.301 0.000
W20-W49 Exposure to inanimate mechanical forces
0.699 0.301 0.000
R70-R79 Abnormal findings on examination of blood, without diagnosis
0.698 0.302 0.000
Z51.9 Medical care, unspecified
0.698 0.302 0.000
Z51.6 Desensitisation to allergens
0.698 0.302 0.000
G70-G73 Diseases of myoneural junction and muscle
0.697 0.303 0.000
R22.0 Localised swelling, mass and lump, head
0.696 0.304 0.000
Y43.9 Primarily systemic agent, unspecified
0.696 0.304 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.696 0.304 0.000
Y43.6 Enzymes, not elsewhere classified
0.696 0.304 0.000
Y43.5 Acidifying and alkalising agents
0.696 0.304 0.000
Y43.4 Immunosuppressive agents
0.696 0.304 0.000
Y43.2 Antineoplastic natural products
0.696 0.304 0.000
Y43.1 Antineoplastic antimetabolites
0.696 0.304 0.000
Y43.0 Antiallergic and antiemetic drugs
0.696 0.304 0.000
F31.0 Bipolar affective disorder, current episode hypomanic
0.695 0.305 0.000
C18 Malignant neoplasm of colon
0.695 0.305 0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease
0.694 0.306 0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes
0.691 0.309 0.000
F38 Other mood [affective] disorders
0.690 0.310 0.000
F34 Persistent mood [affective] disorders
0.690 0.310 0.000
F30 Manic episode
0.690 0.310 0.000
F39 Unspecified mood [affective] disorder
0.690 0.310 0.000
S40-S49 Injuries to the shoulder and upper arm
0.687 0.313 0.000
S51.9 Open wound of forearm, part unspecified
0.686 0.314 0.000
G97 Postprocedural disorders of nervous system, not elsewhere classified
0.685 0.315 0.000
G00-G09 Inflammatory diseases of the central nervous system
0.684 0.316 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.683 0.316 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.683 0.316 0.000
T39.4 Antirheumatics, not elsewhere classified
0.683 0.316 0.000
T39.2 Pyrazolone derivatives
0.683 0.316 0.000
C92 Myeloid leukaemia
0.682 0.318 0.000
W17 Other fall from one level to another
0.681 0.318 0.000
W16 Diving or jumping into water causing injury other than drowning or submersion
0.681 0.318 0.000
W15 Fall from cliff
0.681 0.318 0.000
W14 Fall from tree
0.681 0.318 0.000
W13 Fall from, out of or through building or structure
0.681 0.318 0.000
W12 Fall on and from scaffolding
0.681 0.318 0.000
W11 Fall on and from ladder
0.681 0.318 0.000
W10 Fall on and from stairs and steps
0.681 0.318 0.000
W09 Fall involving playground equipment
0.681 0.318 0.000
W08 Fall involving other furniture
0.681 0.318 0.000
W07 Fall involving chair
0.681 0.318 0.000
W05 Fall involving wheelchair
0.681 0.318 0.000
W04 Fall while being carried or supported by other persons
0.681 0.318 0.000
W03 Other fall on same level due to collision with, or pushing by, another person
0.681 0.318 0.000
W02 Fall involving ice-skates, skis, roller-skates or skateboards
0.681 0.318 0.000
W01 Fall on same level from slipping, tripping and stumbling
0.681 0.318 0.000
W00 Fall on same level involving ice and snow
0.681 0.318 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.680 0.319 0.000
D03.3 Melanoma in situ of other and unspecified parts of face
0.679 0.321 0.000
W19.3 Sports and athletics area
0.679 0.321 0.000
V20-V29 Motorcycle rider injured in transport accident
0.678 0.321 0.000
T43.2 Other and unspecified antidepressants
0.677 0.323 0.000
O60-O75 Complications of labour and delivery
0.677 0.323 0.000
G81 Hemiplegia
0.677 0.323 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.677 0.323 0.000
S06 Intracranial injury
0.677 0.323 0.000
Z54 Convalescence
0.675 0.325 0.000
Z49 Care involving dialysis
0.675 0.325 0.000
Z44 Fitting and adjustment of external prosthetic device
0.675 0.325 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.675 0.325 0.000
C50.1 Central portion of breast
0.675 0.325 0.000
F32.1 Moderate depressive episode
0.675 0.325 0.000
O46 Antepartum haemorrhage, not elsewhere classified
0.673 0.326 0.000
S09 Other and unspecified injuries of head
0.673 0.327 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.673 0.327 0.000
O02 Other abnormal products of conception
0.672 0.328 0.000
R22.2 Localised swelling, mass and lump, trunk
0.670 0.330 0.000
Y40 Systemic antibiotics
0.669 0.331 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.669 0.331 0.000
O24 Diabetes mellitus in pregnancy
0.668 0.332 0.000
G35-G37 Demyelinating diseases of the central nervous system
0.668 0.332 0.000
C83.3 Large cell (diffuse)
0.667 0.333 0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.667 0.333 0.000
C81.9 Hodgkin's disease, unspecified
0.667 0.333 0.000
C01 Malignant neoplasm of base of tongue
0.666 0.334 0.000
Z30-Z39 Persons encountering health services in circumstances related to reproduction
0.666 0.334 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.665 0.334 0.000
O48 Prolonged pregnancy
0.664 0.336 0.000
Z48.8 Other specified surgical follow-up care
0.663 0.337 0.000
C91.1 Chronic lymphocytic leukaemia
0.663 0.337 0.000
D06 Carcinoma in situ of cervix uteri
0.661 0.339 0.000
C50.0 Nipple and areola
0.660 0.340 0.000
D02 Carcinoma in situ of middle ear and respiratory system
0.660 0.340 0.000
D01 Carcinoma in situ of other and unspecified digestive organs
0.660 0.340 0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.660 0.340 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.657 0.343 0.000
C54 Malignant neoplasm of corpus uteri
0.657 0.343 0.000
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis
0.655 0.344 0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions
0.655 0.345 0.000
O36.6 Maternal care for excessive foetal growth
0.655 0.345 0.000
O26.9 Pregnancy-related condition, unspecified
0.655 0.345 0.000
C57 Malignant neoplasm of other and unspecified female genital organs
0.655 0.345 0.000
C51 Malignant neoplasm of vulva
0.655 0.345 0.000
C58 Malignant neoplasm of placenta
0.655 0.345 0.000
C52 Malignant neoplasm of vagina
0.655 0.345 0.000
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria
0.654 0.346 0.000
G82 Paraplegia and tetraplegia
0.654 0.346 0.000
C53 Malignant neoplasm of cervix uteri
0.654 0.346 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.653 0.347 0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction
0.652 0.347 0.000
F02 Dementia in other diseases classified elsewhere
0.652 0.347 0.000
F09 Unspecified organic or symptomatic mental disorder
0.652 0.347 0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances
0.652 0.347 0.000
O36.9 Maternal care for foetal problem, unspecified
0.652 0.348 0.000
O36.7 Maternal care for viable foetus in abdominal pregnancy
0.652 0.348 0.000
O36.4 Maternal care for intra-uterine death
0.652 0.348 0.000
O36.3 Maternal care for signs of foetal hypoxia
0.652 0.348 0.000
O36.2 Maternal care for hydrops foetalis
0.652 0.348 0.000
O36.1 Maternal care for other isoimmunisation
0.652 0.348 0.000
F01 Vascular dementia
0.651 0.349 0.000
G43.9 Migraine, unspecified
0.649 0.351 0.000
O42 Premature rupture of membranes
0.649 0.351 0.000
S01 Open wound of head
0.648 0.352 0.000
S02.4 Fracture of malar and maxillary bones
0.647 0.353 0.000
F32.0 Mild depressive episode
0.647 0.353 0.000
W19.8 Other specified place
0.646 0.354 0.000
W19.5 Trade and service area
0.646 0.354 0.000
W19.0 Home
0.646 0.354 0.000
W19.7 Farm
0.646 0.354 0.000
W19.6 Industrial and construction area
0.646 0.354 0.000
W19.1 Residential institution
0.646 0.354 0.000
R20.2 Paraesthesia of skin
0.644 0.356 0.000
C50.6 Axillary tail of breast
0.643 0.357 0.000
W51 Striking against or bumped into by another person
0.643 0.357 0.000
D09 Carcinoma in situ of other and unspecified sites
0.641 0.359 0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.641 0.359 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.640 0.360 0.000
R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis
0.640 0.360 0.000
D04.7 Skin of lower limb, including hip
0.640 0.360 0.000
Z45.9 Adjustment and management of unspecified implanted device
0.640 0.360 0.000
Z45.3 Adjustment and management of implanted hearing device
0.640 0.360 0.000
Z40 Prophylactic surgery
0.639 0.361 0.000
R95-R99 Ill-defined and unknown causes of mortality
0.639 0.361 0.000
D48.0 Bone and articular cartilage
0.639 0.361 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.638 0.362 0.000
C85.0 Lymphosarcoma
0.638 0.362 0.000
D03.7 Melanoma in situ of lower limb, including hip
0.637 0.363 0.000
Z52 Donors of organs and tissues
0.637 0.363 0.000
T40.4 Other synthetic narcotics
0.636 0.364 0.000
O29 Complications of anaesthesia during pregnancy
0.636 0.364 0.000
O23 Infections of genito-urinary tract in pregnancy
0.636 0.364 0.000
O22 Venous complications in pregnancy
0.636 0.364 0.000
O21 Excessive vomiting in pregnancy
0.636 0.364 0.000
O25 Malnutrition in pregnancy
0.636 0.364 0.000
C90.0 Multiple myeloma
0.631 0.369 0.000
R22.7 Localised swelling, mass and lump, multiple sites
0.630 0.369 0.000
T43.9 Psychotropic drug, unspecified
0.630 0.370 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.630 0.370 0.000
T43.6 Psychostimulants with abuse potential
0.630 0.370 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.630 0.370 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.630 0.370 0.000
O32.1 Maternal care for breech presentation
0.629 0.371 0.000
O32.9 Maternal care for malpresentation of foetus, unspecified
0.629 0.371 0.000
O32.6 Maternal care for compound presentation
0.629 0.371 0.000
O32.4 Maternal care for high head at term
0.629 0.371 0.000
O32.3 Maternal care for face, brow and chin presentation
0.629 0.371 0.000
O32.2 Maternal care for transverse and oblique lie
0.629 0.371 0.000
O32.0 Maternal care for unstable lie
0.629 0.371 0.000
G96 Other disorders of central nervous system
0.628 0.372 0.000
G94 Other disorders of brain in diseases classified elsewhere
0.628 0.372 0.000
G90 Disorders of autonomic nervous system
0.628 0.372 0.000
G98 Other disorders of nervous system, not elsewhere classified
0.628 0.372 0.000
G92 Toxic encephalopathy
0.628 0.372 0.000
R40 Somnolence, stupor and coma
0.627 0.373 0.000
G47 Sleep disorders
0.627 0.373 0.000
S51.0 Open wound of elbow
0.626 0.374 0.000
R22.4 Localised swelling, mass and lump, lower limb
0.625 0.374 0.000
S70 Superficial injury of hip and thigh
0.624 0.375 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.624 0.376 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.624 0.376 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.624 0.376 0.000
T42.3 Barbiturates
0.624 0.376 0.000
T42.2 Succinimides and oxazolidinediones
0.624 0.376 0.000
T42.1 Iminostilbenes
0.624 0.376 0.000
T42.0 Hydantoin derivatives
0.624 0.376 0.000
O30.9 Multiple gestation, unspecified
0.623 0.377 0.000
O30.8 Other multiple gestation
0.623 0.377 0.000
O30.2 Quadruplet pregnancy
0.623 0.377 0.000
O30.1 Triplet pregnancy
0.623 0.377 0.000
W19.4 Street and highway
0.623 0.377 0.000
O26.8 Other specified pregnancy-related conditions
0.622 0.377 0.000
B35-B49 Mycoses
0.621 0.379 0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.619 0.381 0.000
F32.8 Other depressive episodes
0.618 0.382 0.000
F00 Dementia in Alzheimer's disease
0.617 0.383 0.000
D04.9 Skin, unspecified
0.616 0.384 0.000
D04.8 Skin of other sites
0.616 0.384 0.000
D04.4 Skin of scalp and neck
0.616 0.384 0.000
D04.2 Skin of ear and external auricular canal
0.616 0.384 0.000
D04.1 Skin of eyelid, including canthus
0.616 0.384 0.000
D04.0 Skin of lip
0.616 0.384 0.000
S59 Other and unspecified injuries of forearm
0.616 0.384 0.000
S58 Traumatic amputation of forearm
0.616 0.384 0.000
S57 Crushing injury of forearm
0.616 0.384 0.000
S56 Injury of muscle and tendon at forearm level
0.616 0.384 0.000
S55 Injury of blood vessels at forearm level
0.616 0.384 0.000
S54 Injury of nerves at forearm level
0.616 0.384 0.000
S53 Dislocation, sprain and strain of joints and ligaments of elbow
0.616 0.384 0.000
S50 Superficial injury of forearm
0.616 0.384 0.000
Z51.4 Preparatory care for treatment, not elsewhere classified
0.616 0.384 0.000
S91 Open wound of ankle and foot
0.615 0.384 0.000
O47.9 False labour, unspecified
0.615 0.385 0.000
D07 Carcinoma in situ of other and unspecified genital organs
0.614 0.385 0.000
C02 Malignant neoplasm of other and unspecified parts of tongue
0.614 0.386 0.000
C73 Malignant neoplasm of thyroid gland
0.613 0.387 0.000
Z43 Attention to artificial openings
0.613 0.387 0.000
C64-C68 Malignant neoplasms of urinary tract
0.613 0.387 0.000
R46 Symptoms and signs involving appearance and behaviour
0.612 0.388 0.000
R43 Disturbances of smell and taste
0.612 0.388 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.612 0.388 0.000
O20 Haemorrhage in early pregnancy
0.612 0.388 0.000
D45 Polycythaemia vera
0.611 0.389 0.000
W06.0 Home
0.611 0.389 0.000
T40.2 Other opioids
0.611 0.389 0.000
O15 Eclampsia
0.610 0.390 0.000
O12 Gestational [pregnancy-induced] oedema and proteinuria without hypertension
0.610 0.390 0.000
O10 Pre-existing hypertension complicating pregnancy, childbirth and the puerperium
0.610 0.390 0.000
O11 Pre-existing hypertensive disorder with superimposed proteinuria
0.610 0.390 0.000
R23.1 Pallor
0.610 0.390 0.000
C50.2 Upper-inner quadrant of breast
0.609 0.391 0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
0.609 0.391 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.608 0.392 0.000
O02.1 Missed abortion
0.607 0.392 0.000
Z45.8 Adjustment and management of other implanted devices
0.607 0.393 0.000
S08 Traumatic amputation of part of head
0.607 0.393 0.000
S07 Crushing injury of head
0.607 0.393 0.000
S05 Injury of eye and orbit
0.607 0.393 0.000
S04 Injury of cranial nerves
0.607 0.393 0.000
S03 Dislocation, sprain and strain of joints and ligaments of head
0.607 0.393 0.000
F60.3 Emotionally unstable personality disorder
0.607 0.393 0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases
0.606 0.394 0.000
G80 Infantile cerebral palsy
0.606 0.394 0.000
G93.3 Postviral fatigue syndrome
0.604 0.396 0.000
F31.8 Other bipolar affective disorders
0.603 0.397 0.000
F31.7 Bipolar affective disorder, currently in remission
0.603 0.397 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.